Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation

Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation

Background Irradiation (IR) and immune checkpoint inhibitor (ICI) combination is a promising treatment modality. However, local and distance treatment failure and resistance can occur. To counteract this resistance, several studies propose CD73, an ectoenzyme, as a potential target to improve the an...

Full description

Bibliographic Details
Main Authors: Pierre-Antoine Laurent, Eric Deutsch, Michele Mondini, Marine Gerbé De Thoré, Winchygn Liu, Lydia Meziani, Céline Clémenson, Marie-Catherine Vozenin
Format: Article
Language:English
Published: BMJ Publishing Group 2023-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/6/e006846.full

Internet

https://jitc.bmj.com/content/11/6/e006846.full

Similar Items